La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Medtronic Résultats passés
Passé contrôle des critères 0/6
Medtronic's earnings have been declining at an average annual rate of -2.8%, while the Medical Equipment industry saw earnings growing at 11.2% annually. Revenues have been growing at an average rate of 1.6% per year. Medtronic's return on equity is 7.3%, and it has net margins of 11.4%.
Informations clés
-2.8%
Taux de croissance des bénéfices
-2.6%
Taux de croissance du BPA
Medical Equipment Croissance de l'industrie | 8.9% |
Taux de croissance des recettes | 1.6% |
Rendement des fonds propres | 7.3% |
Marge nette | 11.4% |
Prochaine mise à jour des résultats | 20 Aug 2024 |
Mises à jour récentes des performances passées
Recent updates
Medtronic: Still A Buy Before Earnings
Aug 17Returns At Medtronic (NYSE:MDT) Appear To Be Weighed Down
Aug 08Medtronic: An Out Of Favor Healthcare Stock With A Pulse On Profit Potential
Jul 16At US$77.06, Is Medtronic plc (NYSE:MDT) Worth Looking At Closely?
Jul 11Medtronic (NYSE:MDT) Is Paying Out A Larger Dividend Than Last Year
Jun 27Medtronic: Why I Disagree With The Crowd
Jun 14Medtronic's (NYSE:MDT) Upcoming Dividend Will Be Larger Than Last Year's
Jun 10Medtronic: Net Income Could Fall $3.38B, The Stock Would Still Be Undervalued
May 27Medtronic (NYSE:MDT) Has Announced That It Will Be Increasing Its Dividend To $0.70
May 26These 4 Measures Indicate That Medtronic (NYSE:MDT) Is Using Debt Reasonably Well
May 22Medtronic Stock Looks Promising Before Fiscal Q4 2024 Release
May 13Is Medtronic plc (NYSE:MDT) Trading At A 20% Discount?
May 0135% Undervalued? Medtronic's Future Looks Very Bright
Apr 12Medtronic: Buy This Dividend Aristocrat Diamond In The Rough Now
Mar 27Medtronic: Undervalued Medical Devices Stock With Robust Demand And Strong Dividend Growth
Mar 11Medtronic (NYSE:MDT) Has Announced A Dividend Of $0.69
Mar 11Medtronic: Its Recent Beat Proves That It Continues To Be A Rock
Feb 25Results: Medtronic plc Beat Earnings Expectations And Analysts Now Have New Forecasts
Feb 22Medtronic: A Good Choice For Dividend Investors Seeking For Low Volatility
Feb 16A Look At The Fair Value Of Medtronic plc (NYSE:MDT)
Jan 31Does Medtronic (NYSE:MDT) Have A Healthy Balance Sheet?
Jan 16Medtronic Stock's Rally Is Set To Continue
Jan 11Medtronic plc's (NYSE:MDT) Price Is Out Of Tune With Earnings
Dec 29Medtronic's (NYSE:MDT) Dividend Will Be $0.69
Dec 12Medtronic: The GLP-1 Drug Headwinds Are Overblown
Dec 103.5% Yield And Over 15% Annual Return Potential - I Really Like Medtronic
Nov 28Returns On Capital At Medtronic (NYSE:MDT) Have Hit The Brakes
Nov 19Medtronic: 3 Key Issues To Consider Ahead Of Fiscal Q2 2024 Earnings
Nov 17Medtronic Faces Potential Decline Despite Financial Strength
Oct 29An Intrinsic Calculation For Medtronic plc (NYSE:MDT) Suggests It's 21% Undervalued
Oct 19Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Oct 04Medtronic: Improved Guidance, Historically Cheap P/E, Yield Reaches 3.5%
Sep 27Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Sep 18Medtronic: The Tide Is Turning
Aug 24Medtronic (NYSE:MDT) Is Paying Out A Dividend Of $0.69
Aug 21Medtronic: Dark Clouds Are Clearing - Outperformance Ahead
Aug 14Return Trends At Medtronic (NYSE:MDT) Aren't Appealing
Aug 11Medtronic: Expanding Product Portfolio Without Affecting Dividend Growth
Jul 15Are Medtronic plc (NYSE:MDT) Investors Paying Above The Intrinsic Value?
Jul 09Is Medtronic (NYSE:MDT) A Risky Investment?
Jun 21Medtronic: Weak Forecasts Spoiled Strong Results For The Reporting Quarter
Jun 21Is Medtronic's Dividend In A Good Place?
Jun 14Medtronic (NYSE:MDT) Is Increasing Its Dividend To $0.69
Jun 03Medtronic: Solid Q4 Earnings, Don't Fret About Guidance
May 26Ventilation des recettes et des dépenses
Comment Medtronic gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
---|---|---|---|---|
26 Apr 24 | 32,364 | 3,676 | 10,183 | 2,735 |
26 Jan 24 | 32,320 | 4,201 | 12,000 | 2,701 |
27 Oct 23 | 31,958 | 4,102 | 11,884 | 2,693 |
28 Jul 23 | 31,558 | 3,620 | 11,860 | 2,672 |
28 Apr 23 | 31,227 | 3,758 | 10,004 | 2,696 |
27 Jan 23 | 30,771 | 4,064 | 11,825 | 2,707 |
28 Oct 22 | 30,806 | 4,321 | 11,749 | 2,688 |
29 Jul 22 | 31,070 | 5,205 | 11,698 | 2,688 |
29 Apr 22 | 31,686 | 5,039 | 10,047 | 2,746 |
28 Jan 22 | 31,785 | 4,914 | 10,015 | 2,726 |
29 Oct 21 | 31,798 | 4,704 | 9,957 | 2,659 |
30 Jul 21 | 31,597 | 3,882 | 9,997 | 2,622 |
30 Apr 21 | 30,117 | 3,606 | 9,956 | 2,493 |
29 Jan 21 | 27,926 | 2,892 | 9,543 | 2,429 |
30 Oct 20 | 27,868 | 3,537 | 9,661 | 2,401 |
31 Jul 20 | 27,927 | 4,412 | 9,644 | 2,365 |
24 Apr 20 | 28,913 | 4,789 | 9,882 | 2,331 |
24 Jan 20 | 31,062 | 5,408 | 11,857 | 2,357 |
25 Oct 19 | 30,891 | 4,762 | 11,889 | 2,345 |
26 Jul 19 | 30,666 | 4,420 | 10,105 | 2,332 |
26 Apr 19 | 30,557 | 4,631 | 10,273 | 2,330 |
25 Jan 19 | 30,555 | 4,826 | 11,912 | 2,328 |
26 Oct 18 | 30,378 | 2,168 | 11,844 | 2,326 |
27 Jul 18 | 29,947 | 3,163 | 9,963 | 2,292 |
27 Apr 18 | 29,953 | 3,104 | 10,077 | 2,256 |
26 Jan 18 | 29,725 | 2,859 | 11,993 | 2,217 |
27 Oct 17 | 29,639 | 5,069 | 11,878 | 2,188 |
28 Jul 17 | 29,934 | 4,115 | 9,813 | 2,186 |
28 Apr 17 | 29,710 | 4,028 | 9,715 | 2,193 |
27 Jan 17 | 29,361 | 3,968 | 9,592 | 2,215 |
28 Oct 16 | 29,012 | 4,242 | 9,521 | 2,231 |
29 Jul 16 | 28,725 | 3,647 | 9,448 | 2,222 |
29 Apr 16 | 28,833 | 3,538 | 9,469 | 2,224 |
29 Jan 16 | 28,435 | 2,434 | 9,513 | 2,177 |
30 Oct 15 | 25,819 | 2,316 | 8,683 | 2,004 |
31 Jul 15 | 23,127 | 2,624 | 7,847 | 1,833 |
24 Apr 15 | 20,261 | 2,675 | 6,904 | 1,640 |
23 Jan 15 | 17,410 | 3,124 | 6,039 | 1,497 |
24 Oct 14 | 17,255 | 2,909 | 6,006 | 1,484 |
25 Jul 14 | 17,083 | 2,983 | 5,937 | 1,482 |
25 Apr 14 | 16,893 | 3,065 | 5,847 | 1,477 |
24 Jan 14 | 16,879 | 3,586 | 5,783 | 1,501 |
25 Oct 13 | 16,743 | 3,812 | 5,730 | 1,517 |
Des revenus de qualité: MDT has a large one-off loss of $1.3B impacting its last 12 months of financial results to 26th April, 2024.
Augmentation de la marge bénéficiaire: MDT's current net profit margins (11.4%) are lower than last year (12.1%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: MDT's earnings have declined by 2.8% per year over the past 5 years.
Accélération de la croissance: MDT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: MDT had negative earnings growth (-2.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (5.5%).
Rendement des fonds propres
ROE élevé: MDT's Return on Equity (7.3%) is considered low.